These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36796039)

  • 1. 0.18 MG FLUOCINOLONE ACETONIDE INSERT FOR THE TREATMENT OF CHRONIC POSTOPERATIVE PSEUDOPHAKIC CYSTOID MACULAR EDEMA.
    Deaner JD; Mammo D; Gross A; Lee T; Sharma S; Srivastava SK; Jaffe GJ; Grewal DS
    Retina; 2023 Jun; 43(6):897-904. PubMed ID: 36796039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS.
    Kiernan DF
    Retin Cases Brief Rep; 2024 Jul; 18(4):421-427. PubMed ID: 36657153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
    Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
    Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluocinolone acetonide intravitreal implant (Retisert
    Leinonen S; Immonen I; Kotaniemi K
    Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
    Adams OE; Schechet SA; Hariprasad SM
    Eur J Ophthalmol; 2021 Mar; 31(2):612-619. PubMed ID: 31964171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
    Jaffe GJ; Pavesio CE;
    Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
    Studsgaard A; Clemmensen KØ; Nielsen MS
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
    Shen BY; Punjabi OS; Lowder CY; Sears JE; Singh RP
    Retina; 2013 Apr; 33(4):873-7. PubMed ID: 23407350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Institution Experience of Intravitreal 0.18-mg Fluocinolone Acetonide Implant for Noninfectious Uveitis.
    Reddy AK; Pecen PE; Patnaik JL; Palestine AG
    Ophthalmol Retina; 2023 Jan; 7(1):67-71. PubMed ID: 35820567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for persisting cystoid macular edema after penetrating keratoplasty.
    Jonas JB; Kamppeter B
    Cornea; 2006 Feb; 25(2):240-1. PubMed ID: 16371793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
    Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
    Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
    Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
    Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INJECTABLE FLUOCINOLONE IMPLANT FOR THE MANAGEMENT OF CHRONIC POSTSURGICAL CYSTOID MACULAR EDEMA IN VITRECTOMIZED EYES.
    Patel KG; Flores J; Abbey AM
    Retina; 2023 Oct; 43(10):1732-1737. PubMed ID: 37267632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S
    Acta Ophthalmol Scand; 2003 Dec; 81(6):648-52. PubMed ID: 14641270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
    Retina; 2005; 25(7):846-50. PubMed ID: 16205562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.
    Karasu B; Kesim E; Kaskal M; Celebi ARC
    Cutan Ocul Toxicol; 2022 Dec; 41(4):310-317. PubMed ID: 36308286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.